Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03237572
Title Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer (Breast-48)
Acronym Breast-48
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Patrick Dillon, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.